Form 4: STAAR Surgical Director Stephen Farrell Acquires Shares and Options
SEC Form 4
Director Stephen Farrell acquired shares and options in STAAR Surgical Co. on June 20, 2024, as part of the company's non-employee director equity compensation program.
Summary
- Stephen Farrell, a director of STAAR Surgical Co., reported changes in beneficial ownership on June 24, 2024.
- On June 20, 2024, Farrell acquired 2,244 shares of common stock at $0.00 and was granted options to purchase 4,010 shares of common stock at an exercise price of $40.11.
- These transactions were part of the corporation's annual non-employee director equity compensation program for the 2024-2025 term.
- Following the reported transactions, Farrell beneficially owns 15,156 shares of common stock and options to purchase 4,010 shares.
- The equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices, indicating confidence in the company's future.
Positives
- The acquisition of shares and options by a director signals confidence in the company's future performance.
- The equity compensation program aligns the director's interests with those of the shareholders.
- The vesting schedule provides an incentive for the director to remain engaged and contribute to the company's success.
Future Outlook
The document does not contain specific forward-looking statements, but the equity awards vest in full on the earlier of June 20, 2025, or the Corporation's 2025 Annual Meeting of Shareholders.
Industry Context
This type of equity compensation is standard practice for directors of publicly traded companies to align their interests with shareholders.
Comparison to Industry Standards
- Director compensation packages often include a mix of cash and equity.
- The vesting schedule of one year is fairly standard for director equity grants.
- The exercise price of $40.11 for the options is a typical market price at the time of the grant.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive sign.
- Employees may see this as a sign of stability and confidence in the company's leadership.
Key Dates
| Date | Description |
|---|---|
| 06/20/2024 | Date of transaction: acquisition of shares and options. |
| 06/20/2025 | Vesting date for shares and options, or earlier if the Corporation's 2025 Annual Meeting of Shareholders occurs before this date. |
| 06/19/2034 | Expiration date for common stock options. |
| 06/24/2024 | Date of filing the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.